Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

T2 Biosystems CS (TTOO)

T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 242
  • Shares Outstanding, K 21,043
  • Annual Sales, $ 7,190 K
  • Annual Income, $ -50,080 K
  • EBIT $ -42 M
  • EBITDA $ -41 M
  • 60-Month Beta 0.73
  • Price/Sales 0.18
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.89
  • Most Recent Earnings N/A on 11/14/24
  • Next Earnings Date 12/11/25 [--]
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0010 +1,170.00%
on 11/19/25
0.0150 -15.33%
on 12/01/25
+0.0012 (+10.43%)
since 11/11/25
3-Month
0.0010 +1,170.00%
on 11/19/25
0.0800 -84.13%
on 10/15/25
+0.0072 (+130.91%)
since 09/11/25
52-Week
0.0002 +6,250.00%
on 08/28/25
0.4900 -97.41%
on 12/12/24
-0.4623 (-97.33%)
since 12/11/24

Most Recent Stories

More News
T2 Biosystems Expands International Market Presence with Sale of Four T2Dx® Instruments to European Distributor

T2 Biosystems sold four T2Dx® Instruments to expand its international presence in sepsis-testing technology.Quiver AI SummaryT2 Biosystems, Inc. announced the sale of four T2Dx® Instruments to its European...

TTOO : 0.0127 (+10.43%)
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor

TTOO : 0.0127 (+10.43%)
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally

TTOO : 0.0127 (+10.43%)
T2 Biosystems Extends Supplier Agreement with Vizient Through March 2026 for Rapid Sepsis Detection Products

T2 Biosystems extends its agreement with Vizient, enhancing hospital access to rapid sepsis diagnostics through 2026.Quiver AI SummaryT2 Biosystems, Inc. has announced the extension of its supplier agreement...

TTOO : 0.0127 (+10.43%)
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.

TTOO : 0.0127 (+10.43%)
T2 Biosystems Announces Licensing Plans to Enhance Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

T2 Biosystems announced plans to license its technology for direct-from-whole-blood detection of sepsis-causing pathogens, aiming to expand market access.Quiver AI SummaryT2 Biosystems, Inc. has announced...

TTOO : 0.0127 (+10.43%)
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

TTOO : 0.0127 (+10.43%)
T2 Biosystems: Q3 Earnings Snapshot

T2 Biosystems: Q3 Earnings Snapshot

TTOO : 0.0127 (+10.43%)
T2 Biosystems Announces Third Quarter 2024 Financial Results

TTOO : 0.0127 (+10.43%)
What to Expect From Cardinal Health's Q1 2025 Earnings Report

Cardinal Health is expected to release its fiscal first-quarter earnings next month, and analysts project a single-digit profit decline.

XLV : 153.60 (+0.96%)
$SPX : 6,887.85 (+0.02%)
TTOO : 0.0127 (+10.43%)
CAH : 198.24 (+0.02%)

Business Summary

T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens,...

See More

Key Turning Points

3rd Resistance Point 0.0122
2nd Resistance Point 0.0118
1st Resistance Point 0.0117
Last Price 0.0127
1st Support Level 0.0112
2nd Support Level 0.0108
3rd Support Level 0.0107

See More

52-Week High 0.4900
Fibonacci 61.8% 0.3029
Fibonacci 50% 0.2451
Fibonacci 38.2% 0.1873
Last Price 0.0127
52-Week Low 0.0002

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar